MS
New money, same old Wall Street appetite
Morgan Stanley Investment Management says funds run by its Expansion Capital arm led a $33 million growth financing for Subtle Medical, an AI software company trying to make medical imaging faster, cleaner, and less of a logistical headache.
Think of it like putting a turbocharger on the hospital scanner room. Subtle Medical’s software is aimed at improving workflow efficiency and image quality across MRI, PET, and CT — which is exactly the kind of boring-sounding, potentially-valuable problem that gets investors leaning forward in their chairs.
Why you should care
This is not Morgan Stanley buying a company or swinging a giant M&A hammer. But it is a reminder that the firm’s investment arm is still hunting for growth deals in sectors with real upside.
The round also brought in Shinhan Venture Investment and existing backers including Fusion Fund, EnvisionX, BRV, and Samsung Ventures. Translation: this isn’t a lonely bet — it’s a group chat with a check attached.
Big picture: AI health tech still has a line out the door
For Morgan Stanley, the move is more about optionality and exposure than a near-term needle-mover for earnings. For the market, it’s another small but useful data point that AI isn’t just about chatbots and robot dogs; it’s creeping into the unglamorous parts of healthcare where speed and image quality can actually change outcomes.
Big picture: Wall Street keeps finding ways to invest in the picks-and-shovels side of AI, and apparently hospital scans are next in line.